Karen Sleeman

1.4k total citations
10 papers, 1.0k citations indexed

About

Karen Sleeman is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, Karen Sleeman has authored 10 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 3 papers in Microbiology and 2 papers in Infectious Diseases. Recurrent topics in Karen Sleeman's work include Pneumonia and Respiratory Infections (5 papers), Respiratory viral infections research (3 papers) and Bacterial Infections and Vaccines (3 papers). Karen Sleeman is often cited by papers focused on Pneumonia and Respiratory Infections (5 papers), Respiratory viral infections research (3 papers) and Bacterial Infections and Vaccines (3 papers). Karen Sleeman collaborates with scholars based in United Kingdom, Switzerland and Jordan. Karen Sleeman's co-authors include Christopher Dye, Brian Williams, Geoffrey P. Garnett, Derrick W. Crook, David Griffiths, Martin Maiden, Sunetra Gupta, E. Richard Moxon, Tim Peto and Fiona Shackley and has published in prestigious journals such as The Lancet, Journal of Clinical Microbiology and The Journal of Infectious Diseases.

In The Last Decade

Karen Sleeman

10 papers receiving 982 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karen Sleeman United Kingdom 9 689 452 266 147 94 10 1.0k
Limangeni Mankhambo Malawi 17 590 0.9× 523 1.2× 170 0.6× 213 1.4× 40 0.4× 29 1.3k
Josip Begovać Croatia 21 649 0.9× 679 1.5× 136 0.5× 163 1.1× 103 1.1× 111 1.3k
P. Jan Geiseler United States 13 554 0.8× 397 0.9× 210 0.8× 98 0.7× 69 0.7× 22 1.0k
Pravi Moodley South Africa 22 792 1.1× 1.1k 2.4× 192 0.7× 99 0.7× 224 2.4× 94 1.6k
Philip J. Peters United States 20 638 0.9× 761 1.7× 113 0.4× 300 2.0× 107 1.1× 71 1.4k
Robert Newnham United Kingdom 12 613 0.9× 471 1.0× 276 1.0× 106 0.7× 340 3.6× 13 1.3k
Clayton Chiu Australia 17 627 0.9× 281 0.6× 144 0.5× 70 0.5× 52 0.6× 30 1.0k
Ana María Henao-Restrepo Switzerland 14 565 0.8× 408 0.9× 131 0.5× 156 1.1× 28 0.3× 25 1.0k
Per Björkman Sweden 24 1.0k 1.5× 881 1.9× 162 0.6× 123 0.8× 203 2.2× 92 1.7k
Peter Vink United States 22 754 1.1× 686 1.5× 168 0.6× 293 2.0× 94 1.0× 34 1.5k

Countries citing papers authored by Karen Sleeman

Since Specialization
Citations

This map shows the geographic impact of Karen Sleeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Sleeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Sleeman more than expected).

Fields of papers citing papers by Karen Sleeman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Sleeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Sleeman. The network helps show where Karen Sleeman may publish in the future.

Co-authorship network of co-authors of Karen Sleeman

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Sleeman. A scholar is included among the top collaborators of Karen Sleeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Sleeman. Karen Sleeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Bonhoeffer, Jan, Adwoa Bentsi-Enchill, Robert T. Chen, et al.. (2008). Guidelines for collection, analysis and presentation of vaccine safety data in pre- and post-licensure clinical studies. Vaccine. 27(16). 2282–2288. 39 indexed citations
2.
Bonhoeffer, Jan, Adwoa Bentsi-Enchill, Robert T. Chen, et al.. (2008). Guidelines for collection, analysis and presentation of vaccine safety data in surveillance systems. Vaccine. 27(16). 2289–2297. 28 indexed citations
3.
Sleeman, Karen, David Griffiths, Fiona Shackley, et al.. (2006). Capsular Serotype–Specific Attack Rates and Duration of Carriage ofStreptococcuspneumoniaein a Population of Children. The Journal of Infectious Diseases. 194(5). 682–688. 196 indexed citations
4.
Sleeman, Karen, David Griffiths, Jonathan J Deeks, et al.. (2005). Acquisition of Streptococcus pneumoniae and Nonspecific Morbidity in Infants and Their Families. The Pediatric Infectious Disease Journal. 24(2). 121–127. 46 indexed citations
5.
Bennett, Julia S., David Griffiths, Noel McCarthy, et al.. (2005). Genetic Diversity and Carriage Dynamics ofNeisseria lactamicain Infants. Infection and Immunity. 73(4). 2424–2432. 57 indexed citations
6.
Brueggemann, Angela B., Mark C. Enright, Karen Sleeman, et al.. (2003). Stability of Serotypes during Nasopharyngeal Carriage of Streptococcus pneumoniae. Journal of Clinical Microbiology. 41(1). 386–392. 55 indexed citations
7.
Peacock, Sharon J., Anita Justice, David Griffiths, et al.. (2003). Determinants of Acquisition and Carriage ofStaphylococcus aureusin Infancy. Journal of Clinical Microbiology. 41(12). 5718–5725. 141 indexed citations
8.
Sleeman, Karen, Kyle Knox, Robert C. George, et al.. (2001). Invasive Pneumococcal Disease in England and Wales: Vaccination Implications. The Journal of Infectious Diseases. 183(2). 239–246. 101 indexed citations
9.
Bates, Geoff, et al.. (2000). The role of MucodyneR in reducing the need for surgery in patients with persistent otitis media with effusion. Clinical Otolaryngology. 25(4). 274–279. 2 indexed citations
10.
Dye, Christopher, Geoffrey P. Garnett, Karen Sleeman, & Brian Williams. (1998). Prospects for worldwide tuberculosis control under the WHO DOTS strategy. The Lancet. 352(9144). 1886–1891. 353 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Limangeni Mankhambo Breakdown of academic impact, for papers by Josip Begovać Breakdown of academic impact, for papers by P. Jan Geiseler Breakdown of academic impact, for papers by Pravi Moodley Breakdown of academic impact, for papers by Philip J. Peters Breakdown of academic impact, for papers by Robert Newnham Breakdown of academic impact, for papers by Clayton Chiu Breakdown of academic impact, for papers by Ana María Henao-Restrepo Breakdown of academic impact, for papers by Per Björkman Breakdown of academic impact, for papers by Peter Vink
Rankless by CCL
2026